Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
9,026,959
-
Share change
-
+4,584,105
-
Total reported value
-
$110,305,488
-
Price per share
-
$12.22
-
Number of holders
-
52
-
Value change
-
+$55,565,244
-
Number of buys
-
19
-
Number of sells
-
27
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q2 2022
As of 30 Jun 2022,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,026,959 shares.
The largest 10 holders included
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Private Advisor Group, LLC, PNC Financial Services Group, Inc., Mirae Asset Global Investments Co., Ltd., McGuire Investment Group, LLC, One Capital Management, LLC, Portland Global Advisors LLC, UBS Group AG, Raymond James Financial Services Advisors, Inc., and Elmwood Wealth Management, Inc..
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.